Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
APSC Consensus on PCI for Stenosis of LMCA
Author(s): Jack Tan Wei Chieh , Huay Cheem Tan , Michael Kang-Yin Lee , et al Added: 1 year ago

Intervention

Prevention & Chronic Conditions
CTO-PCI in Elderly in a High IVUS Centre
Author(s): Heng Shee Kim , Shinji Imura , Motosu Ando , et al Added: 1 year ago

Intervention

Prevention & Chronic Conditions
PCI Patient Outcomes With Different DES
Author(s): Jonathan Ong Wei Sheng , Muhammad Bin Idu Jion , Keh Yann Shan , et al Added: 9 months ago

Intervention
The QFR-DECISION-PCI Study
Author(s): Samshol Sukahri , Ahmad Syadi Mahmood Zuhdi , Kok Han Chee , et al Added: 1 year ago

Intervention

MI/ACS
ESC 23: The OCTIVUS Study
Author(s): Do-Yoon Kang , Added: 2 years ago
ESC 2023 — We are joined onsite by Dr Duk-Woo Park and Dr Do-Yoon Kang (Asan Medical Center, Seoul, KR) to discuss the findings from the OCTIVUS study (NCT03394079). The OCTIVUS study (Seung-Jung Park, CardioVascular Research Foundation, Korea) aims to compare the clinical safety and efficacy of optimal coherence tomography (OCT) guided and intravascular ultrasound (IVUS) guided strategies in… View more

Intervention
The QUADRIC Study
Author(s): Wei Juan Lim , David Yong Tat Wei , Yuen Han Lim , et al Added: 8 months ago

Intervention

Prevention & Chronic Conditions
TCT 2025: 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
Author(s): Evald Høj Christiansen Added: 1 month ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA… View more

Intervention

Prevention & Chronic Conditions
EuroPCR 24: Influence of Pathophysiological Patterns of CAD on PCI
Author(s): Carlos Collet Added: 1 year ago
EuroPCR 24 - We are joined onsite by Dr Carlos Collet (OLV Hospital Aalst, BE) to discuss the findings from a study analysing the influences of the pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI.The study aimed to assess the capacity of pullback pressure gradient (PPG) in predicting post-PCI fractional flow ratio (FFR), as well as the impact of PPG on… View more

Intervention
ACC.24: FFR or Culprit-Only PCI in STEMI
Author(s): Felix Böhm Added: 1 year ago
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI).1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions… View more

Intervention

MI/ACS
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI
Author(s): Sripal Bangalore , Harriette Van Spall Added: 1 month ago
AHA Scientific Sessions 2025 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) was joined by the TUXEDO-2 Principal Investigator, Dr Sripal Bangalore to present the findings of this late-breaking randomized trial comparing ticagrelor versus prasugrel in patients with diabetes mellitus and multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI)… View more

Anticoagulation

Intervention